The Impact of a Heart Failure Management Protocol Based on a Hospital-community Pharmacist Collaboration

Overview

Journal J Pharm Health Care Sci

Publisher Biomed Central

Specialty Pharmacology

Date 2025 Mar 13

PMID 40075535

Authors

Junichi Terashima

Takahiro Kambara

Eisei Hori

Masahiro Fukatsu

Yukina Ichiki

Eri Oki

Risako Koketsu

Rika Taguchi

Suzuka Mii

Ryoka Hiro

Teruhiro Sakaguchi

Hiroyuki Osanai

Tomoya Tachi

Tadashi Suzuki

Affiliations

Soon will be listed here.

Abstract

Background: Heart failure has a high readmission rate, but interventions by multiple professionals are effective. Although there is growing interest in the management of heart failure by community pharmacists in Japan, no effective method has been developed. We created and verified the effectiveness of a novel heart failure management protocol that community pharmacists could utilize.

Methods: This study included 68 patients (80.8 ± 11.8 years; male, 60.3%) diagnosed with heart failure who was admitted to our hospital between March 2022 and September 2023. A protocol was developed for the regular follow-up of patients and responses to exacerbations, in collaboration with pharmacists. Patients who were able to receive follow-up from community pharmacists were included in the intervention group, otherwise they were included in the control group. The primary endpoint was readmission, and the secondary endpoint was a composite of readmission, all-cause death, hospitalization, and dialysis due to dehydration or renal dysfunction.

Results: The Kaplan-Meier analysis (p = 0.021) and Cox model (hazard ratio: 0.28, 95% confidence interval: 0.09-0.89, p = 0.031) revealed a significantly lower incidence of heart failure readmission within 360 days in the intervention group than in the control group.

Conclusions: The implementation of a heart failure management protocol that provides clear guidance on appropriate patient management enabled pharmacists to effectively reduce the likelihood of adverse events, such as heart failure readmission.

The Registration Number: UMIN000046750, registered on February 1, 2022.

References

Tsuchihashi-Makaya M, Hamaguchi S, Kinugawa S, Yokota T, Goto D, Yokoshiki H . Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). Circ J. 2009; 73(10):1893-900. DOI: 10.1253/circj.cj-09-0254. View

Tsuchihashi-Makaya M, Matsuo H, Kakinoki S, Takechi S, Kinugawa S, Tsutsui H . Home-based disease management program to improve psychological status in patients with heart failure in Japan. Circ J. 2013; 77(4):926-33. DOI: 10.1253/circj.cj-13-0115. View

Jasinska-Stroschein M, Waszyk-Nowaczyk M . Multidimensional Interventions on Supporting Disease Management for Hospitalized Patients with Heart Failure: The Role of Clinical and Community Pharmacists. J Clin Med. 2023; 12(8). PMC: 10142526. DOI: 10.3390/jcm12083037. View

Krumholz H, Amatruda J, Smith G, Mattera J, Roumanis S, Radford M . Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. J Am Coll Cardiol. 2002; 39(1):83-9. DOI: 10.1016/s0735-1097(01)01699-0. View

Parajuli D, Kourbelis C, Franzon J, Newman P, McKinnon R, Shakib S . Effectiveness of the Pharmacist-Involved Multidisciplinary Management of Heart Failure to Improve Hospitalizations and Mortality Rates in 4630 Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Card Fail. 2019; 25(9):744-756. DOI: 10.1016/j.cardfail.2019.07.455. View

Cheng-Lai A, Prlesi L, Murthy S, Bellin E, Sinnett M, Goriacko P . Evaluating Pharmacist-Led Heart Failure Transitions of Care Clinic: Impact of Analytic Approach on Readmission Rate Endpoints. Curr Probl Cardiol. 2022; 48(2):101507. DOI: 10.1016/j.cpcardiol.2022.101507. View

Gattis W, Hasselblad V, Whellan D, OConnor C . Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med. 1999; 159(16):1939-45. DOI: 10.1001/archinte.159.16.1939. View

Madelaire C, Gustafsson F, Stevenson L, Kristensen S, Kober L, Andersen J . One-Year Mortality After Intensification of Outpatient Diuretic Therapy. J Am Heart Assoc. 2020; 9(14):e016010. PMC: 7660734. DOI: 10.1161/JAHA.119.016010. View

Chaudhry S, Wang Y, Concato J, Gill T, Krumholz H . Patterns of weight change preceding hospitalization for heart failure. Circulation. 2007; 116(14):1549-54. PMC: 2892745. DOI: 10.1161/CIRCULATIONAHA.107.690768. View

10.

Weber Z, Kaur P, Hundal A, Ibriga S, Bhatwadekar A . Effect of the pharmacist-managed cardiovascular risk reduction services on diabetic retinopathy outcome measures. Pharm Pract (Granada). 2019; 17(1):1319. PMC: 6463412. DOI: 10.18549/PharmPract.2019.1.1319. View

11.

Tsuchihashi M, Tsutsui H, Kodama K, Kasagi F, Takeshita A . Clinical characteristics and prognosis of hospitalized patients with congestive heart failure--a study in Fukuoka, Japan. Jpn Circ J. 2001; 64(12):953-9. DOI: 10.1253/jcj.64.953. View

12.

Sato Y, Kuragaichi T, Nakayama H, Hotta K, Nishimoto Y, Kato T . Developing Multidisciplinary Management of Heart Failure in the Super-Aging Society of Japan. Circ J. 2022; 88(1):2-9. DOI: 10.1253/circj.CJ-22-0675. View

13.

Jones C, Holmes G, DeWalt D, Erman B, Broucksou K, Hawk V . Is adherence to weight monitoring or weight-based diuretic self-adjustment associated with fewer heart failure-related emergency department visits or hospitalizations?. J Card Fail. 2012; 18(7):576-84. PMC: 3389375. DOI: 10.1016/j.cardfail.2012.05.004. View

14.

Ahmed A, Husain A, Love T, Gambassi G, DellItalia L, Francis G . Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J. 2006; 27(12):1431-9. PMC: 2443408. DOI: 10.1093/eurheartj/ehi890. View

15.

Stewart S, Marley J, Horowitz J . Effects of a multidisciplinary, home-based intervention on unplanned readmissions and survival among patients with chronic congestive heart failure: a randomised controlled study. Lancet. 1999; 354(9184):1077-83. DOI: 10.1016/s0140-6736(99)03428-5. View

16.

Suzuki M, Matsue Y, Izumi S, Kimura A, Hashimoto T, Otomo K . Pharmacist-led intervention in the multidisciplinary team approach optimizes heart failure medication. Heart Vessels. 2017; 33(6):615-622. DOI: 10.1007/s00380-017-1099-8. View

17.

Luder H, Frede S, Kirby J, Epplen K, Cavanaugh T, Martin-Boone J . TransitionRx: Impact of community pharmacy postdischarge medication therapy management on hospital readmission rate. J Am Pharm Assoc (2003). 2015; 55(3):246-54. DOI: 10.1331/JAPhA.2015.14060. View

18.

Rich M, Beckham V, Wittenberg C, Leven C, Freedland K, Carney R . A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995; 333(18):1190-5. DOI: 10.1056/NEJM199511023331806. View

19.

Tsuchihashi-Makaya M, Matsuo H, Kakinoki S, Takechi S, Tsutsui H . Rationale and design of the Japanese heart failure outpatients disease management and cardiac evaluation (J-HOMECARE). J Cardiol. 2011; 58(2):165-72. DOI: 10.1016/j.jjcc.2011.04.004. View